← Back to signals
GILD
STRONG BUYGilead Sciences Inc.
Health Care
0.43
PEGY ratio
Rank #174
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 41.9% annually over 5 years. Pays a 2.5% dividend yield.
GILD is trading at 19.2x earnings against 41.9% growth + 2.5% yield, giving a PEGY of 0.43. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-04-24
Valuation
19.2x
P/E Ratio
Growth
41.9%
5yr EPS
Income
2.5%
Div Yield
PEGY Components
PEGY Score0.43
Denominator44.4%
EPS (TTM)$6.78
Market Data
Price$130.40
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
0.46→0.43(-0.03)
Rank
#126→#174(48 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only